Bertrand C. Liang
Directeur Technique/Scientifique/R&D chez PURPLE BIOTECH LTD
Postes actifs de Bertrand C. Liang
Sociétés | Poste | Début | Fin |
---|---|---|---|
PURPLE BIOTECH LTD | Directeur Technique/Scientifique/R&D | 09/01/2020 | - |
Pico Pharmaceuticals, Inc. | Directeur/Membre du Conseil | 08/12/2009 | - |
Asphelia Pharmaceuticals, Inc. | Directeur/Membre du Conseil | 08/12/2009 | - |
Corporate Officer/Principal | - | 08/12/2009 | |
LCC Ventures | Directeur/Membre du Conseil | 08/12/2009 | - |
Corporate Officer/Principal | - | - | |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Bertrand C. Liang
Anciens postes connus de Bertrand C. Liang
Sociétés | Poste | Début | Fin |
---|---|---|---|
PFENEX INC. | Directeur/Membre du Conseil | 30/12/2010 | 23/01/2017 |
Directeur Général | 08/12/2009 | 23/01/2017 | |
Fondateur | 01/12/2009 | 23/01/2017 | |
President | 01/12/2009 | 23/01/2017 | |
Secrétaire Général | 01/12/2009 | 23/01/2017 | |
LA JOLLA PHARMACEUTICAL COMPANY | Directeur/Membre du Conseil | 08/12/2010 | 19/01/2012 |
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Gestionnaire de Portefeuille-Actions | - | 30/04/2007 |
University of Vermont | Corporate Officer/Principal | - | - |
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░ | - | - | |
░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Bertrand C. Liang
Regis University | Masters Business Admin |
The University of Bolton | Doctorate Degree |
Boston University | Undergraduate Degree |
Feinberg School of Medicine | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 21 |
Japon | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 10 |
Corporate Officer/Principal | 9 |
Founder | 3 |
Sectorielle
Health Technology | 11 |
Consumer Services | 7 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 6 |
---|---|
TRACON PHARMACEUTICALS, INC. | Health Technology |
AMGEN INC. | Health Technology |
IDEC CORPORATION | Electronic Technology |
BIOGEN INC. | Health Technology |
FORTRESS BIOTECH, INC. | Health Technology |
PURPLE BIOTECH LTD | Health Technology |
Entreprise privées | 11 |
---|---|
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount BioSciences LLC (Paramount) is a venture capital firm founded in 1991. The firm is headquartered in New york. | Finance |
TRF Pharma, Inc.
TRF Pharma, Inc. Pharmaceuticals: MajorHealth Technology TRF Pharma, Inc. develops pharmaceutical products. It specializes in the fields of hematology and oncology. The firm's services include developing therapies to treat diseases related to aberrant cell adhesion and endothelial walls. The company was founded by Stephen H. Embury and Neil Matsui in 2002 and is headquartered in Burlingame, CA. | Health Technology |
Balboa Biosciences, Inc.
Balboa Biosciences, Inc. BiotechnologyHealth Technology Balboa Biosciences, Inc. operates as a biopharmaceutical company. It develops therapeutics for central nervous system disorders. The company is headquartered in San Diego, CA. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Paramount BioCapital Asset Management, Inc.
Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
LCC Ventures | |
Asphelia Pharmaceuticals, Inc. | |
Pico Pharmaceuticals, Inc. | |
La Jolla Pharmaceutical Co.
La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Bertrand C. Liang
- Expérience